UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049839
Receipt number R000056772
Scientific Title Very Long-Term Treatment with a Lactobacillus Probiotic Preparation, Lactobacillus Casei Strain Shirota
Date of disclosure of the study information 2022/12/21
Last modified on 2022/12/20 13:49:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Very Long-Term Treatment with a Lactobacillus Probiotic Preparation, Lactobacillus Casei Strain Shirota

Acronym

ABCD Study

Scientific Title

Very Long-Term Treatment with a Lactobacillus Probiotic Preparation, Lactobacillus Casei Strain Shirota

Scientific Title:Acronym

ABCD Study

Region

Japan


Condition

Condition

Colorectal tumors resected

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy and mechanism of lactobacillus preparations against various diseases.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

life and death

Key secondary outcomes

Carcinogenesis
Colorectal Disease


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who previously participated in randomized clinical trials of lactobacilli and dietary fiber

Key exclusion criteria

malignant tumors
a history of intestinal or gastric resection, except appendectomy
familial adenomatous polyposis
severe illness

Target sample size

406


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Ishikawa

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Molecular-Targeting Prevention

Zip code

541-0042

Address

3-2-17-2F Imabashi, Chuo-ku, Osaka 541-0042, Japan

TEL

06-6202-5444

Email

cancer@gol.com


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Ishikawa

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Molecular-Targeting Prevention

Zip code

541-0042

Address

3-2-17-2F Imabashi, Chuo-ku, Osaka 541-0042, Japan

TEL

06-6202-5444

Homepage URL


Email

cancer@gol.com


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

self-financing

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto Prefectural University of Medicine

Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, JAPAN

Tel

075-251-5337

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

237

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 12 Month 01 Day

Date of IRB

2015 Year 12 Month 01 Day

Anticipated trial start date

2016 Year 10 Month 11 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Once a year, we will monitor the status of life, death, and disease by letter.


Management information

Registered date

2022 Year 12 Month 20 Day

Last modified on

2022 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056772


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name